CJC-1295 (Mod GRF 1-29) & Hexarelin Blend (10mg) – Premium Synergistic GH Research Peptide

Welcome to Liaocheng Yixin Company, your trusted source for premium cjc-1295 hexarelin 10mg blend for research. As a specialized peptide synthesis manufacturer operating from our facility at No. 9 Lushan Road, Dongcheng Street, Liaocheng Economic and Technological Development Zone, Shandong Province, we provide high-quality research compounds for the global scientific community.

This 10mg blend combines CJC-1295 (without DAC, also known as Modified GRF 1-29) with Hexarelin, creating a powerful research tool that activates complementary receptor pathways in the anterior pituitary . The combination is of particular research interest because Hexarelin exhibits strong cardioprotective activity independent of its GH-releasing effects, while CJC-1295 provides sustained pulsatile GH stimulation . Our cjc-1295 hexarelin 10mg blend for research offers investigators a convenient, precisely formulated tool for endocrine signaling, cardiovascular, and growth hormone axis studies.

What is the CJC-1295 & Hexarelin Blend?

This 10mg lyophilized blend combines two research peptides that work through complementary mechanisms. CJC-1295 (without DAC) is a tetrasubstituted GHRH analog that activates the GHRH receptor on anterior pituitary somatotrophs, driving cAMP/PKA-mediated GH synthesis and secretion . Hexarelin is a synthetic hexapeptide growth hormone secretagogue that engages the GHS-R1a receptor through Gq/11-coupled signaling, mobilizing intracellular calcium to trigger GH granule release .

Component Profile:

Mechanism of Action in Research

The blend combines two distinct pathways to amplify growth hormone release through synergistic action:

CJC-1295 – GHRH Receptor Pathway

CJC-1295 (without DAC) functions as a selective agonist of the GHRH receptor (GHRH-R), a G protein-coupled receptor expressed on somatotroph cells in the anterior pituitary gland. Binding to the GHRH-R activates the Gs-adenylate cyclase-cAMP-PKA signaling cascade, promoting both the transcription of the growth hormone gene and the exocytotic release of stored GH-containing secretory granules . Without the Drug Affinity Complex (DAC), the peptide has a plasma half-life of approximately 30 minutes, producing a discrete, time-limited GH pulse that closely mimics the endogenous pulsatile pattern of GH secretion .

Hexarelin – GHS-R1a and CD36 Receptor Binding

Hexarelin engages the GHS-R1a receptor through Gq/11-coupled signaling, mobilizing intracellular calcium to trigger GH granule release . Critically, Hexarelin also binds the scavenger receptor CD36, which mediates many of its GH-independent cardioprotective effects including anti-atherosclerotic and anti-ischemic activity .

Synergistic Amplification

The combination of GHRH pathway (cAMP/PKA) and ghrelin pathway (PLC/PKC/Ca2+) activation produces synergistic GH release that substantially exceeds the sum of individual peptide effects . CJC-1295 sustains physiologic pulsatile GH secretion while Hexarelin elevates basal GH tone and suppresses hypothalamic somatostatin . The CJC-1295/Hexarelin stack is considered the most potent secretagogue combination for acute GH pulse amplitude .

Scientific Research Applications

Growth Hormone Secretagogue Research

This blend is the gold standard for maximum GH output studies. In comparative studies, hexarelin produced GH peaks of 40-80 mcg/L as monotherapy, compared to 15-30 mcg/L for ipamorelin and 20-40 mcg/L for GHRP-2 at equivalent doses . When combined with GHRH analogs, hexarelin-based combinations consistently produced the highest peak amplitudes .

Cardioprotective Research

Hexarelin has been extensively studied for direct cardiac effects. In diabetic rat models, in vivo hexarelin treatment improved cardiomyocyte function independent of glycemic control . Hexarelin also protected rat cardiomyocytes from ischemia/reperfusion injury through interleukin-1 signaling pathway modulation, reducing infarct size and preserving contractile function . These cardioprotective effects, mediated partly through CD36 rather than GHS-R1a, are complementary to the systemic anabolic benefits of CJC-1295-driven GH elevation .

Body Composition and Recovery Research

GH pulse amplitude is a key determinant of downstream effects including IGF-1 elevation, protein synthesis stimulation, lipolysis, and collagen synthesis . Research in GH-deficient models demonstrates that pulsatile GH administration is more effective than continuous infusion for promoting lean body mass and reducing adiposity, supporting the value of high-amplitude pulse protocols . cjc-1295 hexarelin 10mg blend for research

Muscle Preservation and Anti-Cachexia Research

Hexarelin has shown protective effects against chemotherapy-induced muscle wasting. In cisplatin-induced cachexia models, Hexarelin prevented dysregulation of skeletal muscle calcium homeostasis, preserving excitation-contraction coupling and muscle fiber integrity . Combined with CJC-1295’s sustained GH axis stimulation, this stack provides both GH-dependent anabolic signaling and GH-independent muscle-protective effects .

Why Choose Liaocheng Yixin Company?

When sourcing cjc-1295 hexarelin 10mg blend for research, quality and reliability are paramount. Here’s why researchers trust us:

Manufacturer-Direct Quality

We are a legitimate, licensed peptide synthesis company with a physical headquarters in Shandong Province, China. Our facility maintains strict quality control standards.

Verified Purity Standards

Every batch undergoes rigorous testing using HPLC analysis. Certificates of Analysis are available upon request.   cjc-1295 hexarelin 10mg blend for research

Research-Grade Specifications

• Purity: ≥99% verified by HPLC

• Appearance: White lyophilized powder

• Storage: Store powder at -20°C in a sealed, desiccated container, protected from light and moisture

• Form: Lyophilized powder for research use

•  cjc-1295 hexarelin 10mg blend for research

Quality Assurance & Testing

Every batch undergoes comprehensive quality control:

1. Synthesis by experienced chemists using solid-phase peptide synthesis

2. Purification via preparative HPLC

3. Analysis using HPLC for purity verification

4. Mass Spectrometry for molecular weight confirmation

5. Packaged in sterile conditions for research use

6.  cjc-1295 hexarelin 10mg blend for research

: How does the CJC-1295 and Hexarelin blend work in research?

A: CJC-1295 activates the GHRH receptor on pituitary somatotrophs, while Hexarelin engages the GHS-R1a receptor and CD36. This dual pathway activation produces synergistic GH release that substantially exceeds the sum of individual peptide effects . The combination represents the most potent secretagogue stack for acute GH pulse amplitude .

: What makes Hexarelin unique among GHRPs? cjc-1295 hexarelin 10mg blend for research

A: Hexarelin produces the highest GH peak amplitude among all GHRPs—approximately 25% more than GHRP-2 and significantly more than ipamorelin. It also binds CD36 receptors, providing GH-independent cardioprotective effects .

: What are the key research applications for this blend?

A: This blend is used in growth hormone secretagogue research (synergy studies), cardioprotective research (ischemia/reperfusion models), body composition studies, and muscle preservation/anti-cachexia research . cjc-1295 hexarelin 10mg blend for research

: What purity level can I expect?

A: All batches are tested to ensure ≥99% purity by HPLC analysis. Certificates of Analysis are available upon request.

: Is this product for human use?

A: No. This blend is manufactured strictly for research use only (RUO). It is not intended for human consumption or clinical applications.

When you need premium cjc-1295 hexarelin 10mg blend for research for your endocrine, cardioprotective, or metabolic studies, choose a manufacturer that prioritizes quality, transparency, and reliability. Liaocheng Yixin Company combines expert peptide synthesis capabilities with rigorous quality control to deliver research materials you can trust.